Identifying Cancer Tissue of Origin using Plasma Whole Genome Sequencing

使用血浆全基因组测序识别癌症组织起源

• 批准号: 488922
• 负责人: Stein Lincoln
• 金额: $ 71.33万
• 依托单位: Ontario Institute for Cancer Research (Toronto, Ontario)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-09-01 至 2027-09-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=488922&lang=en
• 关键词: Artificial Intelligence; Cancer; Genomics; Liquid Biopsy; Machine Learning; Pwgs; Tumour Origin

Recent progress in cancer detection and treatment has led to a new issue. People who have survived cancer for many years now have a higher chance of getting a completely different type of cancer later on in life. This is called "multiple primary cancers."

癌症检测和治疗的最新进展带来了一个新问题。在癌症中存活多年的人现在更有可能在以后的生活中患上完全不同类型的癌症。这称为“多原发性癌症”。